Chun-Jen Liu
Chun-Jen Liu is an expert in Hepatology at National Taiwan University Hospital (Taiwan). As of October 2026, ScienceLeadR ranks Chun-Jen Liu in the top 1% of experts worldwide for Hepatitis. Chun-Jen Liu has authored 414 publications, the most recent in 2026, and is an investigator in 30 clinical trials, 5 of them ongoing. SLR score: 1,699 (community average: 125). How the SLR is computed.
LeadR Profile
Hepatology
Subspecialties: Gastroenterology - Infectiology
Main Topics
Publications and Clinical Studies
Profile data updated on
Organizations
Career arc: 1997 - 2026
Number : 414
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Taiwan GEST-TASL-TMASO Joint Position Statement in Managing Metabolic Dysfunction-Associated Steatotic Liver Disease and Obesity. PMID 42922180 — liver diseases, fibrosis, non-alcoholic fatty liver disease, liver, bariatric surgery, prevalence, obesity, precision medicine, gastrointestinal microbiome | Liver Int | 2026 | 0 |
| Clinical Risk Factors for Advanced Fibrosis in Pathology-Proven Steatotic Liver Disease: Emphasis on Nonelder Subjects. PMID 42899427 — liver diseases, diabetes mellitus, gastroenterology, fibrosis, pathology, liver, obesity, risk factors, infections, hepatitis, diabetes mellitus, type 2 | J Gastroenterol Hepatol | 2026 | 0 |
| Serum Golgi Protein 73 as a Noninvasive Marker of Hepatic Fibrosis in Chronic Hepatitis C Virus Infection. PMID 42895453 — hepatitis c, chronic, hepatitis c, serum, fibrosis, hepatitis, chronic, viruses, infections, hepatitis, virus diseases | J Med Virol | 2026 | 0 |
| Sex Difference in the Impact of Steatotic Liver Disease on Incident Hepatocellular Carcinoma in Patients with Chronic Hepatitis B. PMID 42738400 — liver diseases, diabetes mellitus, tenofovir, carcinoma, hepatocellular, cohort studies, hepatitis, chronic, liver, aged, sex characteristics, sex, hepatitis b, hepatitis b, chronic, hepatitis, sex differences | Cancers (Basel) | 2026 | 1 |
| Gender differences in stigma and care avoidance among people living with MASLD: an international survey. PMID 42686023 — liver diseases, non-alcoholic fatty liver disease, liver, retention in care, sex characteristics, sex differences | JHEP Rep | 2026 | 0 |
Clinical Studies 30
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
5 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Development of Microbial Therapeutics for Metabolic associated Fatty Liver Disease From Mechanistic Investigations to Clinical Trials NCT06873165 — liver diseases, liver, capsules, probiotics, therapeutics, fatty liver, akkermansia | N/A | Recruiting | 2025 |
| Chronic Hepatitis B Patients With Concurrent MAFLD Cohort Study and Exercise Intervention NCT05956379 — liver diseases, exercise, physical therapists, swimming, exercise test, non-alcoholic fatty liver disease, cohort studies, prescriptions, hepatitis, chronic, liver, alcoholics, hepatitis a, walking, jogging, hepatitis b, fatty liver, gastrointestinal microbiome, metabolic syndrome, fatty liver, alcoholic, microbiota, hepatitis b, chronic, infections, hepatitis | N/A | Enrolling by invitation | 2023 |
| Comparing P1101 to Entecavir in Patients With HBeAg( ) Hepatitis B Under Long term Nucleos(t)Ide Analogue Therapy NCT05494528 — injections, hepatitis b virus, herpesviridae infections, nucleosides, hepatitis, chronic, herpesviridae, herpesvirus 1, cercopithecine, viruses, hepatitis a, hepatitis b e antigens, therapeutics, hepatitis b, injections, subcutaneous, hepatitis b, chronic, infections, hepatitis, virus diseases | N/A | Recruiting | 2021 |
| Disease Loads and Status of Treatment NCT05264272 — diabetes mellitus, hepatitis b surface antigens, tea, creatinine, hepatitis d, coffee, hepatitis, chronic, hepatitis a, genotype, hepatitis b e antigens, therapeutics, blood platelets, history, hepatitis b, dna, smoking, hepatitis b, chronic, infections, hepatitis, child, rna | N/A | Recruiting | 2022 |
| Research Study on Whether Semaglutide Works in People With Non alcoholic Steatohepatitis (NASH) NCT04822181 — liver diseases, skin, non-alcoholic fatty liver disease, liver, alcoholics, research, fatty liver, fatty liver, alcoholic, semaglutide | Phase 3 | Active not recruiting | 2021 |
LeadR Networks
Main global connection map